The Lyme Disease Association announces that the House voted this week to pass a number of amendments to the NDAA, National Defense Authorization Act, including a Congressman Chris Smith amendment – The Comptroller General of the United States shall conduct a review of whether the Department of Defense experimented with ticks, other insects, airborne releases […]
This section contains information on legislation that has been introduced and/or passed by the federal government. It includes sections that contain the position the Lyme Disease Association (LDA) has taken on various bills, if any, and information on how to contact your legislator; and what you can do to help specific laws be passed or defeated. Additionally, there is a section on various government departments. From time to time, the LDA will post articles from the departments/agencies in these sections that pertain to Lyme disease that might be of interest or importance to the public, including policies being considered or adopted.
It is important for the LDA to take a lead role in forming relationships with all levels of government. Laws and policy decisions often affect how Lyme disease is viewed by the public and physicians, and LDA needs to clearly articulate the problems which are created by government actions or which can be rectified by government actions. Additionally, we need to ensure that the information presented to government officials is accurate and supported by science.
In a new study published by the CDC, Effects of COVID-19 Pandemic on Reported Lyme Disease, United States, 2020, authors describe how the impacts of COVID-19 might have influenced Lyme disease case reporting in 2020. Investigators explored 4 data sources to assess how the COVID-19 pandemic may have influenced reporting of Lyme disease cases in […]
In a recent study conducted by the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) serum samples were analyzed from free-ranging white-tailed deer for SARS-CoV-2 antibodies. Researchers found that a cohort of white-tailed deer populations from Illinois, Michigan, New York, and Pennsylvania were exposed to SARS-CoV-2. The USDA-APHIS has published an […]
July 29–The Lyme Disease Association is pleased to announce that Congressman Chris Smith (NJ-4) has been successful in have 2 bipartisan amendments to increase Lyme disease funding by $8 M pass the House today. The Amendments are part of the House consideration of Labor HHS and Education and Related Agencies Appropriations Act. One amendment enables the […]
The RI Resolution S0711 introduced by Senator Stephen Archambault (RI 22-D), which was amended on the floor, requests the RI Department of Health to increase public awareness of Lyme activities that expose people to ticks, educate on symptoms of Lyme and importance of early detection, and to update physician protocols with regard to early detection […]
The HHS Tick-Borne Disease Working Group (WG) of 2021-2022 will hold its first meeting on August 26, 2021. The details of the meeting can be found on the HHS TBD Working Group website. Verbal comments and written comments can be submitted according to rules on the website. This term is the last segment of the WG, which was mandated by the passage of the 21st Century Cures Act signed into law in 2016.
The Lyme Disease Association Inc. urges you to read the URGENT letter to CPAP & BiPAP device customers from Phillips Respironics below on details of the recall if you have any connection to these devices. The devices are listed in the recall notice and on the website. According to the Customer Letter, “These issues can […]
In a letter to physicians, the Maryland Department of Health (MDH) warns doctors to pay attention to Lyme which is the most frequently diagnosed tick-borne disease (TBD) in Maryland residents (1400 cases 2019). The MDH also cautions them to report other TBDs, which it specifically names. The letter also points out the similarities of Lyme […]
Data from a survey of respondents with self-reported tick bite encounters who concurrently reported a clinical or serological Lyme disease (LD) diagnosis from non-endemic states for Lyme disease was published in the journal Healthcare, June 21, 2021. Focusing on Texas, which due to large size, diverse climate, and ecological conditions, reflects environments that promote ticks, […]
Increased cases of myocarditis and pericarditis have been reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna) since April 2021, particularly in adolescents and young adults. These rates for ages 16-24 following a second dose are above what is expected. Myocarditis or pericarditis has now been verified in 226 people ages 30 and younger who have received an mRNA COVID-19 vaccine and Federal Health Officials are investigating reports of approximately 250 more cases.
Due to this increase, the Advisory Committee on Immunization Practices (ACIP) is scheduled to hold an emergency meeting on June 18, 2021 to discuss myocarditis cases and the American Academy of Pediatrics (AAP) plans to closely monitor meeting.